Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

9

Number of overlapping holdings

30.0%

% of PJP's 30 holdings also in PPH

37.5%

% of PPH's 27 holdings also in PJP

Overlap by Weight
Sector Drift (PJP minus PPH)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in PJP
Weight
in PPH
Overlap
ELI LILLY & CO 5.4% 12.4% 5.4%
ABBVIE INC 5.0% 5.9% 5.0%
MERCK & CO. INC. 5.2% 5.0% 5.0%
BRISTOL-MYERS SQUIBB CO 4.9% 5.7% 4.9%
JOHNSON & JOHNSON 4.8% 6.4% 4.8%

Position Highlights (Non-Overlapping Exposures)
PJP Overweight Relative to PPH
ABBOTT LABORATORIES 4.9%
AMGEN INC 4.7%
TARSUS PHARMACEUTICALS, INC. 3.1%
GILEAD SCIENCES INC 2.8%
SUPERNUS PHARMACEUTICALS INC 2.8%
UNITED THERAPEUTICS CORP 2.8%
COLLEGIUM PHARMACEUTICAL, INC. 2.7%
REGENERON PHARMACEUTICALS 2.7%
PRESTIGE BRANDS HOLDINGS INC 2.7%
LIQUIDIA TECHNOLOGIES, INC. 2.7%
PJP Underweight Relative to PPH
NOVO-NORDISK A/S-SPONS ADR -8.1%
ELI LILLY & CO -7.0%
MCKESSON CORP -5.6%
AMERISOURCEBERGEN CORP -4.9%
NOVARTIS AG-ADR -4.7%
ZOETIS INC -4.7%
ASTRAZENECA PLC-SPONS ADR -4.6%
TAKEDA PHARMACEUTICAL CO. LTD. SPONS -4.5%
SANOFI-AVENTIS-ADR -4.0%
GLAXOSMITHKLINE PLC-SPON ADR -3.9%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY